Filing Flows › Ocugen (OCGN) › Q2 2026 › vs Q1 2026
Ocugen (OCGN) Q2 2026 vs Q1 2026 (quarter over quarter)
Ocugen's revenue fell $45K (-3%) from $1.5M in Q1 2026 to $1.5M in Q2 2026.
Ocugen, Q2 2026: revenue $1.5M (+8% year over year), net loss $24.9M, operating cash flow −$12.2M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $1.5M | $1.5M | −$45K | -3% |
| Net loss | $24.9M | $19.2M | $5.7M | +30% |
| Costs & expenses | $26.4M | $20.7M | $5.7M | +27% |
| Operating costs | $17.9M | $19.4M | −$1.4M | -7% |
| Interest & other, net | $8.4M | $1.3M | $7.1M | +530% |
| Research & development | $10.7M | $11.3M | −$565K | -5% |
| General & admin | $7.2M | $8.1M | −$875K | -11% |
| Operating cash sources | $24.9M | $19.2M | $5.7M | +30% |
| Depreciation | $600K | $600K | $0 | 0% |
| Share-based compensation | $1.8M | $3.4M | −$1.6M | -46% |
| Working capital & other | $10.2M | −$6.6M | $16.9M | — |
| Cash used in operations | $12.2M | $21.8M | −$9.6M | -44% |
| Net loss absorbed | $24.9M | $19.2M | $5.7M | +30% |
Questions
How much did Ocugen's revenue grow quarter over quarter in Q2 2026?
Ocugen's revenue fell $45K (-3%) from $1.5M in Q1 2026 to $1.5M in Q2 2026.